|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PIA VARIABLE ANNUITY ACCOUNT I, 497, 1996-06-13 |
Next: RIDGEWOOD ELECTRIC POWER TRUST IV, 8-K/A, 1996-06-13 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 13, 1996
VIDAMED, INC.
(exact name of registrant as specified in its charter)
Delaware 0-26082 77-0314454
(State or other jurisdiction of (Commission File No.) (IRS Employer
incorporation or organization) Identification No.)
1380 Willow Road, Suite 101
Menlo Park, CA 94025
(Address of principal executive offices)
(415) 328-8781
(Registrant's telephone number, including area code)
Page 1 of 6
<PAGE>
Item 5. Other Events
VidaMed, Inc. (the "Company") is filing unaudited
interim financial statements at and for the period
ended April 30, 1996 to demonstrate that the Company
is in compliance with the continuing listing
standards of the Nasdaq National Market. Such
financial statements are attached hereto as exhibit
99.1.
Item 7. Financial Statements and Exhibits
(c) Exhibits
99.1 Balance Sheet of the Company at April 30, 1996 and
Statement of Operations of the Company for the four months
ended April 30, 1996.
Page 2 of 6
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VIDAMED, INC.
By: /s/ James A. Heisch
-------------------------------
James A. Heisch, President
and Chief Executive Officer
Page 3 of 6
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Balance Sheet of the Company at April 30, 1996 and
Statement of Operations of the Company for the four
months ended April 30, 1996.
Page 4 of 6
EXHIBIT 99.1
<TABLE>
VidaMed, Inc.
Condensed Consolidated Balance Sheets
<CAPTION>
April 30, March 31,
1996 1996
------------ ------------
<S> <C> <C>
Assets
Current Assets:
Cash and cash equivalents $ 7,210,385 $ 11,144,937
Short-term investments 8,887,100 5,913,200
Other current assets 1,907,840 2,338,517
------------ ------------
Total current assets 18,005,325 19,396,654
Property and equipment, net 2,823,907 2,863,987
Other assets, net 227,674 232,289
------------ ------------
Total assets $ 21,056,906 $ 22,492,930
============ ============
Liabilities and stockholders' equity
Current liabilities:
Notes payable, current portion $ 986,474 $ 977,239
Accounts payable 623,046 442,197
Accrued compensation 255,289 252,071
Accrued professional fees 295,969 251,254
Accrued clinical trial costs 879,849 886,394
Accrued and other liabilities 2,955,843 2,948,200
Deferred revenue 637,500 672,917
------------ ------------
Total current liabilities 6,633,970 6,430,272
Notes payable, noncurrent 1,201,814 1,288,339
Convertible notes, noncurrent 1,050,000 10,100,000
Other long-term liabilities 978,882 1,023,929
Stockholders' equity:
Capital stock 53,996,634 45,313,534
Accumulated deficit (42,804,394) (41,663,144)
------------ ------------
Total stockholders' equity 11,192,240 3,650,390
------------ ------------
Total Liabilities and stockholders' equity $ 21,056,906 $ 22,492,930
============ ============
</TABLE>
Page 5 of 6
<PAGE>
VidaMed, Inc.
Condensed Consolidated Statements of Operations
Four
Months Ended
April 30,
1996
-------------
Revenues:
Product sales, net $ 459,693
License fees and grant revenue 143,316
-------------
Net revenues 603,009
Operating Expenses:
Cost of product sales 974,567
Research and development 1,848,787
Selling, general and administrative 2,224,133
------------
Total operating expenses 5,047,487
------------
Loss from operations (4,444,478)
Other expense, net (27,128)
------------
Net loss $(4,471,606)
============
Page 6 of 6
|
|